abstract |
The present invention provides a compound of formula (I) or a pharmaceutically acceptable salt or solvate thereof. The compounds are useful for the treatment of disease states caused by hyperactivity of the VR1 receptor, such as pain or similar disease in mammals. The present invention also provides a pharmaceutical composition comprising the compound.n n n Formula I |